🩸 VTE Prophylaxis Decision — Medical Inpatients (Padua Score)
Assess venous thromboembolism risk in medical inpatients with the Padua Prediction Score and get prophylaxis guidance. Instant, browser-side.
Padua ≥ 4 = high risk → pharmacological prophylaxis (LMWH, low-dose UFH or fondaparinux) absent contraindication.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
Decide whether a medical inpatient needs pharmacological VTE prophylaxis.
How it works
Padua: active cancer 3, prior VTE 3, immobility 3, thrombophilia 3, recent trauma/surgery 2, age ≥ 70 / cardiorespiratory failure / MI-stroke / acute infection-rheumatic / obesity / hormonal therapy 1 each. ≥ 4 = high risk.
Key points
- Padua ≥ 4 = high risk → pharmacological prophylaxis (LMWH, low-dose UFH or fondaparinux) absent contraindication.
- Assess bleeding risk (e.g. IMPROVE bleeding score) before starting prophylaxis.
- Where anticoagulation is contraindicated, use mechanical prophylaxis.
- Padua < 4 = low risk → routine pharmacological prophylaxis not recommended; encourage early mobilisation.
References
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Active cancer | Yes |
|---|---|
| Previous VTE (excluding superficial vein thrombosis) | Yes |
| Reduced mobility (bed rest ≥ 3 days) | Yes |
| Known thrombophilia | Yes |
| Recent (≤ 1 month) trauma or surgery | Yes |
| Age ≥ 70 years | Yes |
| Heart and/or respiratory failure | Yes |
| Acute MI or ischaemic stroke | Yes |
| Acute infection and/or rheumatologic disorder | Yes |
| Obesity (BMI ≥ 30) | Yes |
| Ongoing hormonal treatment | Yes |
→VTE riskHigh
- Padua score:20 points
- Prophylaxis advice:Pharmacological prophylaxis recommended (no contraindication)
- Basis:ACCP / medical-inpatient VTE prevention guidance
| Active cancer | No |
|---|---|
| Previous VTE (excluding superficial vein thrombosis) | No |
| Reduced mobility (bed rest ≥ 3 days) | No |
| Known thrombophilia | No |
| Recent (≤ 1 month) trauma or surgery | No |
| Age ≥ 70 years | No |
| Heart and/or respiratory failure | No |
| Acute MI or ischaemic stroke | No |
| Acute infection and/or rheumatologic disorder | No |
| Obesity (BMI ≥ 30) | No |
| Ongoing hormonal treatment | No |
→VTE riskLow
- Padua score:0 points
- Prophylaxis advice:Routine pharmacological prophylaxis not recommended
- Basis:ACCP / medical-inpatient VTE prevention guidance
Frequently asked questions
- What is VTE Prophylaxis Decision — Medical Inpatients (Padua Score)?
- Assess venous thromboembolism risk in medical inpatients with the Padua Prediction Score and get prophylaxis guidance. Instant, browser-side.
- How is VTE Prophylaxis Decision — Medical Inpatients (Padua Score) calculated? What is the core formula?
- Padua: active cancer 3, prior VTE 3, immobility 3, thrombophilia 3, recent trauma/surgery 2, age ≥ 70 / cardiorespiratory failure / MI-stroke / acute infection-rheumatic / obesity / hormonal therapy 1 each. ≥ 4 = high risk.
- When is VTE Prophylaxis Decision — Medical Inpatients (Padua Score) used?
- Decide whether a medical inpatient needs pharmacological VTE prophylaxis.
- What are the key clinical points for VTE Prophylaxis Decision — Medical Inpatients (Padua Score)?
- Padua ≥ 4 = high risk → pharmacological prophylaxis (LMWH, low-dose UFH or fondaparinux) absent contraindication. Assess bleeding risk (e.g. IMPROVE bleeding score) before starting prophylaxis. Where anticoagulation is contraindicated, use mechanical prophylaxis. Padua < 4 = low risk → routine pharmacological prophylaxis not recommended; encourage early mobilisation.
- What are the limits and cautions when using VTE Prophylaxis Decision — Medical Inpatients (Padua Score)?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is VTE Prophylaxis Decision — Medical Inpatients (Padua Score) calculated in practice? Can you show a worked example?
- Inputs: Active cancer Yes, Previous VTE (excluding superficial vein thrombosis) Yes, Reduced mobility (bed rest ≥ 3 days) Yes, Known thrombophilia Yes, Recent (≤ 1 month) trauma or surgery Yes, Age ≥ 70 years Yes, Heart and/or respiratory failure Yes, Acute MI or ischaemic stroke Yes… → Result: VTE risk High(Padua score: 20 points, Prophylaxis advice: Pharmacological prophylaxis recommended (no contraindication), Basis: ACCP / medical-inpatient VTE prevention guidance) Inputs: Active cancer No, Previous VTE (excluding superficial vein thrombosis) No, Reduced mobility (bed rest ≥ 3 days) No, Known thrombophilia No, Recent (≤ 1 month) trauma or surgery No, Age ≥ 70 years No, Heart and/or respiratory failure No, Acute MI or ischaemic stroke No… → Result: VTE risk Low(Padua score: 0 points, Prophylaxis advice: Routine pharmacological prophylaxis not recommended, Basis: ACCP / medical-inpatient VTE prevention guidance)